Key Takeaways TEVA's Q2 adjusted EPS of 2 cents missed estimates, while revenues of $4.14 billion beat the mark.Teva raised its 2026 revenue outlook to $16.5-$16.85 billion from $16.4-$16.8 billion.Teva lifted its 2026 sales outlook on stronger Austedo, Ajovy and Uzedy revenue expectations.Teva Pharmaceutical Industries Limited (TEVA) reported second-quarter 2026 adjusted earnings of 2 cents per share, which missed the Zacks Consensus Estimate of 8 cents. Adjusted earnings declined 97% year over year due to ...